Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
Press releases published on June 2, 2025
Liberation Labs is Now Liberation Bioindustries
GlobeNewswire
·
June 2, 2025
RICHMOND, Ind., June 02, 2025 (GLOBE NEWSWIRE) -- Liberation Labs has a new name and brand – Liberation Bioindustries. The name and brand refresh better reflect the company’s position as a global, commercial-scale, contract biomanufacturer. The company’s …
ESET Names Ryan Grant as Country Manager, US and Canada
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that Ryan Grant has been promoted to Country Manager for US and Canada, effective June 1. Reporting to Palo Balaj, Chief Business Officer at ESET, Grant …
Actuate Therapeutics Shares Highlights from KOL Event on Positive Topline Elraglusib Phase 2 Data in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
June 2, 2025
- Expert Insights on Clinical Relevance and Scientific Rationale - The replay of the event is available on the Investor Relations section of the Actuate website CHICAGO and FORT WORTH, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. ( …
Bondex’s Native Utility Token $BDXN Secures Listing on Binance Alpha and Futures
GlobeNewswire
·
June 2, 2025
LONDON, UK, June 02, 2025 (GLOBE NEWSWIRE) -- Bondex, the Web3 platform revolutionizing professional trust and credibility, has announced that its native utility token $BDXN will be listed on Binance Alpha, Binance Futures, and other leading exchanges to …
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
GlobeNewswire
·
June 2, 2025
SOLANA BEACH, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, …
As BTC, XRP, and DOGE Fall, RIPPLECOIN MINING Offers a New Route to Passive Income
GlobeNewswire
·
June 2, 2025
Los Angeles, California , June 02, 2025 (GLOBE NEWSWIRE) -- Amid the recent turbulence shaking the crypto market — with Bitcoin (BTC), Ripple (XRP), and Dogecoin (DOGE) experiencing sharp declines — investor confidence has taken a hit, and short-term …
Xilio Therapeutics Announces Pricing of $50.0 Million Public Offering
GlobeNewswire
·
June 2, 2025
WALTHAM, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced the pricing …
Ambiq Names Jeff Winzeler as Chief Financial Officer
GlobeNewswire
·
June 2, 2025
AUSTIN, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Ambiq®, a technology leader in ultra-low-power semiconductor solutions for edge AI, is pleased to announce Jeff Winzeler as Ambiq’s new Chief Financial Officer (CFO). Jeff Winzeler brings extensive CFO and …
AITX's RAD Receives RIO™ Expansion Orders from Major Client
GlobeNewswire
·
June 2, 2025
Latest Orders Part of Ongoing National Rollout of AI-Powered Security Solutions by Leading Logistics Provider Detroit, Michigan, June 02, 2025 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCPK:AITX), a global …
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
GlobeNewswire
·
June 2, 2025
Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth markets Leadership team realigned in order to enable execution of ancillary protein strategy Dyadic is well positioned to seize on geopolitical …
Catalyst Continues Growth with Hirings of Institutional Relations and Portfolio Strategist Professionals
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Capital Advisors LLC, a leading provider of alternative and innovative investment solutions, today announced the hire of Robert Gallant, CFA, CAIA, as Executive Director of Institutional Relations, and …
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025
GlobeNewswire
·
June 2, 2025
Presentation highlights deep and durable responses and radiographic resolution of bone metastases in patients with advanced prostate cancer Final clinical data demonstrate an 87% overall response rate in patients with metastatic prostate cancer Results …
TELA Bio Appoints Jeffrey Blizard as President
GlobeNewswire
·
June 2, 2025
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Jeffrey Blizard as President …
Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update
GlobeNewswire
·
June 2, 2025
VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing novel DNA-damage response (DDR) cancer therapies powered by artificial …
TruGolf Announces Listing Extension from Nasdaq
GlobeNewswire
·
June 2, 2025
Salt Lake City, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, today announced that the Nasdaq Hearings Panel has granted the company an extension of time to comply with Nasdaq listing …
NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking
GlobeNewswire
·
June 2, 2025
BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced plans …
Mersana Therapeutics Reports Additional Positive Interim Phase 1 Clinical Data for Emi-Le in Oral Presentation at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
31% confirmed ORR (8 responses in 26 evaluable patients) across B7-H4 high tumors at intermediate doses 44% confirmed ORR (7 responses in 16 evaluable patients) in the subset of patients with ≤4 prior lines of therapy CAMBRIDGE, Mass., June 02, 2025 (GLOBE …
IMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALS
GlobeNewswire
·
June 2, 2025
Outstanding Phase 2 Results will be discussed at the 2025 ASCO in an Oral Presentation and featured in peer reviewed medical journal Gynecologic Oncology Phase 3 OVATION 3 Study in progress LAWRENCEVILLE, N.J. , June 02, 2025 (GLOBE NEWSWIRE) -- IMUNON, …
Joint Press Release of Constellation Software Inc. and Topicus.com Inc. -- Topicus.com Inc. completes acquisition of Cipal Schaubroeck in Belgium
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX: CSU) and Topicus.com Inc. (TSXV: TOI) today announced that Topicus’ subsidiary Total Specific Solutions (TSS) B.V. (“TSS”) has completed the sale and transfer of all issued and …
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
GlobeNewswire
·
June 2, 2025
CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP as Chief Medical Officer. Dr. Andrews will report directly …